[Translated article] Moderate to Severe Psoriasis in Pediatric and Young Patients: The BIOBADADERM Registry Experience

Autor: L.M. Nieto Benito, G. Carretero, R. Rivera-Díaz, J.M. Carrascosa, E. Daudén, P. de la Cueva, A. Sahuquillo-Torralba, E. Herrera-Acosta, O. Baniandrés-Rodríguez, J.L. Lopez-Estebaranz, I. Belinchón, J. Riera-Monroig, M. Ferrán, F.J. Gómez-García, A. Mateu, L. Rodríguez, J. Vilar-Alejo, C. García-Donoso, F. Ballescá, L.-M. Velasco, R. Botella-Estrada, E. Herrera-Ceballos, D.P. Ruiz-Genao, M.A. Descalzo, I. García-Doval

Publikováno v: Actas Dermo-Sifiliográficas, Vol 113, Iss 4, Pp T401-T406 (2022)

Childhood-onset psoriasis generally follows an indolent course but patients with moderate or severe disease may require systemic treatment. The aim of this study was to determine the relative proportion of children and young people aged up to 21 year

Externí odkaz: https://doaj.org/article/a5b8d61293e04b5d88d08b850d278cde

Moderate to Severe Psoriasis in Pediatric and Young Patients: The BIOBADADERM Registry Experience

Autor: Benito, L. M. Nieto, Carretero, G., Rivera-Diaz, R., Carrascosa, J. M., Dauden, E., de la Cueva, P., Sahuquillo-Torralba, A., Herrera-Acosta, E., Baniandres-Rodriguez, O., Lopez-Estebaranz, J. L., Belinchon, I, Riera-Monroig, J., Ferran, M., Gomez-Garcia, F. J., Mateu, A., Rodriguez, L., Vilar-Alejo, J., Garcia-Donoso, C., Ballesca, F., Velasco, Llamas-M, Botella-Estrada, R., Herrera-Ceballos, E., Ruiz-Genao, D. P., Descalzo, M. A., Garcia-Doval, I, BIOBADADERM Study Grp

Childhood-onset psoriasis generally follows an indolent course but patients with moderate or severe disease may require systemic treatment. The aim of this study was to determine the relative proportion of children and young people aged up to 21 year

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2636::5032bc7490e608f73818e0f88ae3797b
https://hdl.handle.net/10668/21860

Psoriasis moderada-grave en pacientes pediátricos y jóvenes: experiencia en el registro BIOBADADERM

Autor: José Manuel Carrascosa, O Baniandrés-Rodríguez, José L. López-Estebaranz, LM Nieto Benito, M. Ferran, L. Rodríguez, Enrique Herrera-Acosta, Enrique Herrera-Ceballos, Raquel Rivera-Diaz, Ignacio García-Doval, A Sahuquillo-Torralba, C García-Donoso, Isabel Belinchón, E. Daudén, D P Ruiz-Genao, F.J. Gómez-García, A. Mateu, J Vilar-Alejo, F Ballescá, G. Carretero, Miguel Ángel Descalzo, P. de la Cueva, el grupo de estudio Biobadaderm, Rafael Botella-Estrada, J Riera-Monroig, Mar Llamas-Velasco

Resumen {0>El debut de la psoriasis en la edad pediatrica, aunque generalmente leve, puede requerir tratamiento sistemico en las formas moderadas o graves de la enfermedad. Childhood-onset psoriasis generally follows an indolent course but patients w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbbd905ba2b8c9c79e80de1cb21e01f4
http://hdl.handle.net/10230/54996

The risk of urinary tract infections in patients with psoriasis on systemic medications in Biobadaderm Registry: A prospective cohort study

Autor: Sahuquillo-Torralba A, Carretero G, Rivera R, Ferrándiz C, Daudén-Tello E, de la Cueva P, Gómez-García FJ, Belinchón I, Herrera-Acosta E, Ruiz-Genao D, Ferrán M, Alsina M, Sánchez-Carazo JL, Baniandrés O, Fernández-Freire LR, Vilar J, García-Donoso C, Carrascosa JM, Llamas-Velasco M, Herrera-Ceballos E, López-Estebaranz JL, Pujol-Marco C, Descalzo MÁ, García-Doval I, Biobadaderm Study Group

Publikováno v: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe

Biobadaderm is a multicenter prospective cohort that was created to evaluate the safety of systemic therapy for psoriasis patients.2 Once a year, reports are created. In 2018, a signal regarding symptomatic urinary tract infection (UTI) was detected.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d00b37002ea14b9f79f2d6db26c6e1d
https://fundanet.isabial.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=5791

Changing Trends in Drug Prescription and Causes of Treatment Discontinuation of First Biologic Over Ten Years in Psoriasis in the Spanish Biobadaderm Registry

Autor: D P, Ruiz-Genao, G, Carretero, R, Rivera, C, Ferrándiz, E, Daudén, P, de la Cueva, I, Belinchón, F J, Gómez-García, E, Herrera-Acosta, J L, López-Estebaranz, M, Ferrán-Farrés, M, Alsina, O, Baniandrés-Rodríguez, J L, Sánchez-Carazo, A, Sahuquillo-Torralba, L, Rodriguez, J, Vilar-Alejo, C, García-Donoso, J M, Carrascosa, M, Llamas-Velasco, E, Herrera-Ceballos, R, Botella-Estrada, M A, Descalzo, I, García-Doval

Publikováno v: Actas dermo-sifiliograficas
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

Current psoriasis guidelines do not usually include recommendations about first line classical or biologic treatment. The objectives of this study were: to describe shifts in the prescription of the first biological treatment, and to compare treatmen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::95c0966b7085d03c5186fd91d809970b
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=13242